Podcasts about barbers

Got Faded Japan ep 643 “All great circuses and freak shows travel” - The Great Milenko In this most epic of episodes, Johnny travels to the other side of the planet just to get faded with the most spectacular of Faders, Cousin Chris! Yes that's right, Cousin Chris graces us once again with explosive Michigan beer reviews, wildly alcoholic bitter creation tips and of course he blows our minds with his take on the weekly bizarre and wild news! YIPPEE-KI-YAY AND FADE ON!     -------------------------------------------------------------------------------- Supporting GOT FADED JAPAN ON PATREON directly supports keeping this show going and fueled with booze, seriously could you imagine the show sober?? Neither can we! SUPPORT GFJ at: https://www.patreon.com/gotfadedjapan   -------------------------------------------------------------------------------- CHECK OUT OUR SPONSORS AND SUPPORT THE SHOW!!!!   1. THE SPILT INK: Experience art, buy art and get some original art commissioned at: SITE: https://www.thespiltink.com NFT: https://rarible.com/thespiltink ETSY: https://www.etsy.com/shop/TheSpiltInk?ref=hdr_shop_menu --------------------------------------------------------------------------------  2. Soul Food House https://soulfoodhouse.comAddress:2-chōme−8−10 | Azabujūban | Tokyo | 106-0045 Phone:03-5765-2148 Email:info@soulfoodhouse.com Location Features:You can reach Soul Food House from either the Oedo Line (get off at Azabujuban Station and it's a 7-minute walk) or the Namboku Line (get off at Azabujuban Station and it's a 6-minute walk). --------------------------------------------------------------------------------  3. Ghost Town Pomade FADE IN STYLE with Ghost Town Pomade.Get yours today by contacting: ghosttownpomade@gmail.com  -------------------------------------------------------------------------------- 4. MITSUYA LIQUOR in ASAGAYA: 1　Chome- 13 -17 Asagayaminami, Suginami Tokyo 166-0004　 Tel & Fax: 0303314-6151Email: saketoyou0328@gmail.com --------------------------------------------------------------------------------   5. Harry's Sandwich Company 1 min walk from Takeshita Street in HarajukuCall 050-5329-7203 Address: 〒150-0001 Tokyo, Shibuya City, Jingumae, 1 Chome−16−7 MSビル 3F https://www.facebook.com/harryssandwichco/ -------------------------------------------------------------------------------- 6. Share Residence MUSOCO “It's a share house that has all that you need and a lot more!” - Located 30 minutes form Shibuya and Yokohama - Affordable rent - Gym - BAR! - Massive kitchen - Cozy lounge space - Office work units - A spacious deck for chilling - DJ booth and club space - Barber space - AND MORE! Get more info and move in at: https://sharedesign.co.jp/en/property.php?id=42&property=musaco&fbclid=IwAR3oYvB-a3_nzKcBG0gSdPQzxvFaWVWsi1d1xKLtYBnq8IS2uLqe6z9L6kY -------------------------------------------------------------------------------- GET YOURSELF SOME GOT FADED JAPAN MERCH TODAY!!! We have T-Shirts, COFFEE Mugs, Stickers, even the GFJ official pants! BUY NOW AND SUPPORT THE SHOW: http://www.redbubble.com/people/thespiltink/works/16870492-got-faded-japan-podcast  -------------------------------------------------------------------------------- The Got Faded Japan Podcast gives listeners a glimpse of the most interesting side of Japan's news, culture, peoples, parties, and all around mischief and mayhem. Hosted by Johnny and Jeremy who adds opinions and otherwise drunken bullshit to the mix. We LOVE JAPAN AND SO DO YOU! Send us an email on Facebook or hell man, just tell a friend & post a link to keep this pod rolllin' Fader! Kanpai mofos!  

In honor of Oncology Nursing Month in May, Oncology Data Advisor is celebrating the stories of these essential members of the cancer care team. For this interview, editorial board member Maria Badillo, MSN, RN, OCN®, CCRP, speaks with Diane Barber, PhD, ANP-BC, AOCNP®, FAAN, Manager of Advanced Practice Providers at MD Anderson Cancer Center. Dr. Barber explains the importance of building a diverse nursing work force and shares ways to spread awareness about the opportunities that a career in nursing can offer.

Kirk damaged a car at Gateway, Seth damaged a car at Gateway, and Scott did not damage a car at Gateway. Kirk Barber joins us to talk about his circle track roots, mechanic leanings, and engineer training. From working with professional racing teams to teaching engineers, this tall drink of water has the experience to make bold changes and make it work. Kirk's Facebook ------ Track Walking - Facebook Track Walking - Instagram Track Walking Chats - Group

James Walker joins Talkin' Baseball with Marty to talk about his new book -- "Red Barber: The Life and Legacy of a Broadcasting Legend." Red Barber follows the trajectory of Barber's long career from radio and television play-by-play man for the Cincinnati Reds, Brooklyn Dodgers, and New York Yankees to his work calling college and professional football games See omnystudio.com/listener for privacy information.

James Walker joins Talkin' Baseball with Marty to talk about his new book -- "Red Barber: The Life and Legacy of a Broadcasting Legend." Red Barber follows the trajectory of Barber's long career from radio and television play-by-play man for the Cincinnati Reds, Brooklyn Dodgers, and New York Yankees to his work calling college and professional football games See omnystudio.com/listener for privacy information.

The pickup truck is the symbol of rural conservative masculinity. So, it often takes centre stage in the tired culture wars between reactionary neo-populists and liberal moralists. Like today, with Canada's right crudely embracing the truck–and tweeting furiously about those ‘Laurentian elites,‘ and ‘Toronto columnists‘ who thumb their nose at it. But, if you really want … Read More Read More

On this episode we chat to a star in the making. Devons finest musician, Barber and Youtuber. What hasnt this young guy done!!! Ladies and Gents I introduce to you Chay Snowdon

My introduction to swimming and the new introductions since.

Got Faded Japan ep 642 Don't be a bum, get a job in Japan! Tom may not be great at keeping a job but there's one thing that the ol' man can do and that's nail an interview. Learn the ins-and-outs of getting a job in Japan in this action packed episode of Got Faded Japan, oh yeah, and we also get into the weekly bizarre and wild news. FADE ON!     -------------------------------------------------------------------------------- Supporting GOT FADED JAPAN ON PATREON directly supports keeping this show going and fueled with booze, seriously could you imagine the show sober?? Neither can we! SUPPORT GFJ at: https://www.patreon.com/gotfadedjapan   -------------------------------------------------------------------------------- CHECK OUT OUR SPONSORS AND SUPPORT THE SHOW!!!!   1. THE SPILT INK: Experience art, buy art and get some original art commissioned at: SITE: https://www.thespiltink.com NFT: https://rarible.com/thespiltink ETSY: https://www.etsy.com/shop/TheSpiltInk?ref=hdr_shop_menu --------------------------------------------------------------------------------  2. Soul Food House https://soulfoodhouse.comAddress:2-chōme−8−10 | Azabujūban | Tokyo | 106-0045 Phone:03-5765-2148 Email:info@soulfoodhouse.com Location Features:You can reach Soul Food House from either the Oedo Line (get off at Azabujuban Station and it's a 7-minute walk) or the Namboku Line (get off at Azabujuban Station and it's a 6-minute walk). --------------------------------------------------------------------------------  3. Ghost Town Pomade FADE IN STYLE with Ghost Town Pomade.Get yours today by contacting: ghosttownpomade@gmail.com  -------------------------------------------------------------------------------- 4. MITSUYA LIQUOR in ASAGAYA: 1　Chome- 13 -17 Asagayaminami, Suginami Tokyo 166-0004　 Tel & Fax: 0303314-6151Email: saketoyou0328@gmail.com --------------------------------------------------------------------------------   5. Harry's Sandwich Company 1 min walk from Takeshita Street in HarajukuCall 050-5329-7203 Address: 〒150-0001 Tokyo, Shibuya City, Jingumae, 1 Chome−16−7 MSビル 3F https://www.facebook.com/harryssandwichco/ -------------------------------------------------------------------------------- 6. Share Residence MUSOCO “It's a share house that has all that you need and a lot more!” - Located 30 minutes form Shibuya and Yokohama - Affordable rent - Gym - BAR! - Massive kitchen - Cozy lounge space - Office work units - A spacious deck for chilling - DJ booth and club space - Barber space - AND MORE! Get more info and move in at: https://sharedesign.co.jp/en/property.php?id=42&property=musaco&fbclid=IwAR3oYvB-a3_nzKcBG0gSdPQzxvFaWVWsi1d1xKLtYBnq8IS2uLqe6z9L6kY -------------------------------------------------------------------------------- GET YOURSELF SOME GOT FADED JAPAN MERCH TODAY!!! We have T-Shirts, COFFEE Mugs, Stickers, even the GFJ official pants! BUY NOW AND SUPPORT THE SHOW: http://www.redbubble.com/people/thespiltink/works/16870492-got-faded-japan-podcast  -------------------------------------------------------------------------------- The Got Faded Japan Podcast gives listeners a glimpse of the most interesting side of Japan's news, culture, peoples, parties, and all around mischief and mayhem. Hosted by Johnny and Jeremy who adds opinions and otherwise drunken bullshit to the mix. We LOVE JAPAN AND SO DO YOU! Send us an email on Facebook or hell man, just tell a friend & post a link to keep this pod rolllin' Fader! Kanpai mofos!  

On Episode 16 of the Stroke Alert Podcast, Dr. Negar Asdaghi highlights two articles from the May issue of Stroke: “Number of Affected Relatives, Age, Smoking, and Hypertension Prediction Score for Intracranial Aneurysms in Persons With a Family History for Subarachnoid Hemorrhage” and “Endovascular Treatment for Acute Ischemic Stroke With or Without General Anesthesia.” She also interviews Dr. Patrick Lyden on “The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results.” Dr. Negar Asdaghi:         Let's start with some questions. 1) How is it that stroke can be cured in rodents but not in humans? 2) Are we wasting time or gaining time with general anesthesia before endovascular thrombectomy? 3) My father had an aneurysmal subarachnoid hemorrhage, Doctor. What is my risk of having an aneurysm, and how often should we check for one? We're back here with the Stroke Alert Podcast to tackle the toughest questions in the field because this is the best in Stroke. Stay with us. Dr. Negar Asdaghi:         Welcome back to the May 2022 issue of the Stroke Alert Podcast. My name is Negar Asdaghi. I'm an Associate Professor of Neurology at the University of Miami Miller School of Medicine and your host for the monthly Stroke Alert Podcast. For the May 2022 issue of Stroke, we have a number of papers that I'd like to highlight. We have seven articles as part of our Focused Update on the topic of neuroimmunology and stroke, organized by our own Stroke editors, Drs. Johannes Boltze and Miguel Perez-Pinzon. We also have an interesting study by Dr. David Saadoun and colleagues from Sorbonne University in Paris, where we learn that in patients with Takayasu disease, how the delay in diagnosis, as defined by the time from symptom onset to the diagnosis being over one year, was significantly associated with development of ischemic cerebrovascular events. In the Comments and Opinions section, we have an interesting study by Dr. Goldenberg and colleagues from University of Toronto on the benefits of GLP-1 receptor agonists for stroke reduction in type 2 diabetes and why should stroke neurologists be familiar with this new class of diabetic medication. Dr. Negar Asdaghi:         Later, in the interview section of the podcast, I have the great honor of interviewing Dr. Patrick Lyden, one of the founding fathers of thrombolytic therapy in stroke, as he walks us through the Stroke Preclinical Assessment Network and what his hopes are for the future of stroke therapy. I also ask him for some advice, and he did tell us about the view from the top, as he truly stands on the shoulder of giants. But first with these two articles. Dr. Negar Asdaghi:         In a landmark population-based study out of Sweden that was published in Brain in 2008, we learned that the odds of development of aneurysmal subarachnoid hemorrhage for individuals with one first-degree relative with a prior history of aneurysmal subarachnoid hemorrhage was 2.15. For individuals with two affected first-degree relatives, the odds ratio was 51. So, it's not surprising that a great deal of anxiety is caused within a family when a relative has an aneurysmal subarachnoid hemorrhage, especially if that family member was young or another member of the family had the same condition before. This scenario is commonly followed by a number of inevitable questions: Should all family members of the affected individual be screened for presence of an intracranial aneurysm? If yes, how often should vascular imaging be performed, and should other aneurysmal risk factors, such as age, sex, smoking, and hypertension, be also considered in the screening decision-making? In this issue of the journal, as part of a derivation-validation study, a group of investigators, led by Dr. Charlotte Zuurbier from University Medical Center at Utrecht Brain Center in the Netherlands, studied the ability of a simple scoring system that was developed in their derivation cohort to predict the presence of an intracranial aneurysm on vascular imaging. Dr. Negar Asdaghi:         They then tested the scoring model in their validation cohort. So, for their development cohort, they used data on 660 persons who were screened at the University Medical Center for presence of an intracranial aneurysm because they had two or more affected first-degree relatives with a prior history of aneurysmal subarachnoid hemorrhage. The median age of participants at the time of first screening was 40, and 59% were female. Dr. Negar Asdaghi:         So, in this cohort, the investigators simply looked at factors that were independently associated with finding an aneurysm on vascular screening by their multivariate analysis. And they identified the following factors; the first factor was the number of affected relatives. Now, a reminder that all of these people in the cohort had at least two first-degree relatives with an aneurysmal subarachnoid hemorrhage. And they found that amongst these people, those that had three or more family members with aneurysmal subarachnoid hemorrhage were significantly more likely to have a positive screening test for intracranial aneurysm. The next factor was older age — the older that relative, the more likely their screening imaging was positive for an aneurysm — and the other independent factors were smoking and hypertension. So they created the NASH acronym; N for number of relatives, A for age, S for smoking, and H for hypertension. When assigning points for each of these factors, the NASH scoring system had a C statistics of 0.68 in predicting whether or not someone would have a positive test, which is an intracranial aneurysm. Dr. Negar Asdaghi:         And now a reminder for our listeners that C statistics gives us the probability that a person with a certain condition, in this case, a certain NASH score, will have the outcome of interest, in this case, an aneurysm found by vascular imaging. In general, for C statistics, the closer we get to 1, the more robust is our predictive model. Values over 0.7 indicate that we have a good model, but values over 0.8 indicate a very strong model. So the NASH score, at 0.68, has a reasonably good capability in predicting who will or will not have an intracranial aneurysm if we complete the vascular imaging. But it's not a very strong model, and this should be kept in mind. Let's look at some of their numbers. In their development cohort, the probability of finding an intracranial aneurysm for a person who scored low on NASH, that is a young person who never smoked and is not hypertensive, was only 5%, whereas the probability of finding an intracranial aneurysm in a person who scored high on NASH, that is an older person in their 60s or 70s, with three or more affected relatives, who is hypertensive and a smoker, was 36%. Dr. Negar Asdaghi:         So, then they tested this NASH score in their external validation cohort and found that the likelihood of identifying an aneurysm increased as expected along the range of predicted probabilities of NASH. That is, the higher the score, the more likely to find an aneurysm on screening with vascular imaging. And the C statistics in the validation cohort was slightly lower than the C statistics in the derivation cohort. So, the important lesson we learned from this study is that the risk of having an intracranial aneurysm in a person who has a first-degree family member with a prior history of aneurysmal subarachnoid hemorrhage is substantially different depending on their NASH score, and this should be taken into consideration when deciding on screening and counseling various family members of the affected patient or prioritizing who should be screened first in routine practice. Dr. Negar Asdaghi:         The ideal anesthetic management during endovascular therapy is still unknown. A number of studies have compared the different anesthetic options available during thrombectomy, which include general anesthesia, or GA, conscious sedation, use of local anesthesia, and no sedation at all. The main argument for doing endovascular therapy under general anesthesia is that although this procedure will take some precious pre-thrombectomy time, it does result in strict immobility. And that is really ideal in the sense that it improves catheter navigation and interpretation of angiography, in addition to obviously providing a secure airway and, of course, avoiding the need to have to do an emergency intubation in case of procedural complications. The argument against general anesthesia is not only the issue of time but also the risk of hypotension and hemodynamic compromise, especially during induction, and the loss of very valuable neurological examination in a completely sedated patient during the procedure. Dr. Negar Asdaghi:         The question is, does general anesthesia improve or worsen neurological and functional outcomes post-thrombectomy? Several smaller randomized trials have looked at this very question, mainly comparing GA to all other forms of sedation during thrombectomy, but they have yielded inconsistent findings regarding the three-month functional outcome. Dr. Negar Asdaghi:         Some of them showed that patients under GA ended up doing better. Some showed no difference in the overall outcomes. But overall, their pooled analysis suggested that GA might be superior to the competing counterpart, which is the conscious sedation, and associated with better functional outcome. But these centers had highly specialized anesthesia teams, and it's possible that their findings may not be generalizable to routine practice. So, in this issue of the journal, using the Swiss Stroke Registry, Dr. Benjamin Wagner from the Department of Neurology at the University Hospital in Basel and colleagues report on the outcomes of endovascularly treated patients in the Swiss Stroke Registry receiving thrombectomy for an anterior circulation stroke with or without general anesthesia. The primary outcome was disability on the modified Rankin Scale after three months. For this study, they excluded one out of the nine centers in the registry that had lots of missing data on their three-month follow-up. Dr. Negar Asdaghi:         And so, from 2014 to 2017, 1,284 patients across eight stroke centers in the registry were included in this study. Sixty-six percent received thrombectomy under general anesthesia. On baseline comparison, the patients in the GA group were older, had a higher NIH Stroke Scale on admission, had worse preclinical functional status, and more likely to have presented with multi-territorial ischemic stroke. So, many reasons as to why people who underwent general anesthesia would have a worse clinical outcome in this study. So, now let's look at their primary outcome. In the unadjusted model, the three-month modified Rankin Scale was significantly worse in the GA group as compared to the non-GA group, which is obviously expected given the differences in their baseline characteristics. Dr. Negar Asdaghi:         But what was surprising was that the odds of having a higher mRS score was significantly greater still in the adjusted models. They also did propensity score matching analysis, and they found that the NIH Stroke Scale after 24 hours, and the odds of dependency and death and mortality were all higher in the adjusted model in the GA group. They also looked at a number of secondary outcomes and found that door-to-puncture time was longer in the GA group. Dr. Negar Asdaghi:         And also these patients were more likely to be transferred to ICU after treatment as compared to the non-GA treated counterparts. The authors point out that these real-world data are in keeping with the findings from the HERMES meta-analysis, which included over 1,700 endovascularly treated patients, and two previously published large registry data, one from Italy, which included over 4,000 endovascularly treated patients, and one from Germany, including 5,808 patients, all of them showing a worse functional outcome in endovascular therapy if the treatment was performed under general anesthesia, as compared to all other forms of sedation or no sedation at all. Again, these findings are in contrast with the reassuring results of the randomized trials on this topic, specifically in contrast to the AnStroke, SIESTA, and GOLIATH randomized trials, which compare GA to conscious sedation, showing either neutral or positive results in favor of general anesthesia pre-thrombectomy. Dr. Negar Asdaghi:         So, in summary, what we learned from this real-world, observational study is that general anesthesia was associated with worse functional outcome post-endovascular thrombectomy, independent of other confounders, which means that the jury is still out on the ideal form of anesthesia for an individual patient prior to endovascular therapy, and we definitely need larger, multicenter studies on this topic. Dr. Negar Asdaghi:         There are over a thousand experimental treatments that have shown benefit in prevention of neurological disability in animal models of ischemic stroke but have failed to show the same efficacy in human randomized trials. In fact, to date, reperfusion therapies, either in the form of intravenous lytic therapies or endovascular treatments, are the only successful treatments available to improve clinical outcomes in patients who suffer from ischemic stroke, and stroke remains a leading cause of death and disability worldwide. How come stroke can be cured in rodents but not in humans? Are neuroprotective therapies, or as more correctly referred to, the cerebroprotective therapies, the epitome of bench-to-bedside translational research failure? And if this is true, what are the key contributors to the scientific conundrum, and how can this be averted in the future? This is the question that a remarkable group of neuroscientists, led by Dr. Patrick Lyden from University of Southern California, are hoping to answer. Dr. Negar Asdaghi:         In this issue of the journal, these investigators describe the rationale, design, feasibility, and stage 1 results of their multicenter SPAN collaboration, which stands for the Stroke Preclinical Assessment Network. I'm joined today by Professor Lyden himself to discuss this collaboration. Now, Professor Lyden absolutely needs no introduction to our stroke community, but as always, introductions are nice. So, here we go. Dr. Lyden is a Professor of Physiology, Neuroscience, and Neurology at Zilkha Neurogenetic Institute, Keck School of Medicine, at USC. He has truly been a leader in the field of preclinical and clinical vascular research with over 30 years of experience in conducting studies and randomized trials, including conducting the pivotal NINDS clinical trial that led to the approval of the first treatment for acute ischemic stroke in 1996. Throughout his exemplary career, he has accumulated many accolades and is the recipient of multiple awards and honors, including the prestigious 2019 American Stroke Association William Feinberg Award for Excellence in Clinical Stroke. Good morning, Pat, it's truly an honor to welcome you to our podcast today. Dr. Patrick Lyden:            Thanks, I'm glad to be here. Dr. Negar Asdaghi:         Well, in the era of successful reperfusion therapies, it seems that the new generation of stroke neurologists and interventionalists have their eyes, so to speak, on the clock and are interested in opening the blood vessels and opening them fast. In the age of reperfusion treatments, why do we still need to talk about the role of cerebroprotective treatments? Dr. Patrick Lyden:            Well, not to sound too glib about it, but not everybody gets better after a thrombectomy. So, thrombectomy is good, it's more effective than anything else that we've tried before, but there are a remaining number of patients with a residual disability. Not only that, and from a more scientific standpoint, thrombectomy offers us the opportunity now to combine cerebroprotective therapy with known reperfusion. Remember, before, we didn't know when the artery had opened, but now we do an embolectomy, we know there's reperfusion. It gives us the opportunity to know that we're combining our treatment with reperfusion. Dr. Negar Asdaghi:         So, in the paper, you discussed how hundreds of treatments have been studied and shown efficacy in reducing neurological disability in animal models of stroke, and yet failed in human studies. In your opinion, what were the top two most disappointing studies in terms of clinical failure despite pre-clinical encouraging data? Dr. Patrick Lyden:            Well, the first one I mentioned was personal because it was the first one that I led, and it was a molecule called clomethiazole that I had helped establish the rationale for in my very first grant. So, it was the first trial I led, it was multinational, and, of course, I firmly believed we were going to hit a home run, and we failed. But to the field, the real watershed moment in neuroprotective therapy was the so-called SAINT II Trial. SAINT II was a study of a drug called NXY-059, and it was the first drug that purportedly had satisfied all of the so-called STAIR criteria. The STAIR criteria came out of a roundtable between academics and industry on how to best qualify drugs preclinically before going to human trials. And the idea was, if you were a 10 out of 10 on the STAIR criteria, then you should win when you come to human clinical trials. And the SAINT II Trial, which I was a co-leader, a co-investigator, on, also failed. Dr. Patrick Lyden:            And so many, many, many drugs had failed by that point. Tens of millions, if not a hundred million dollars, had been spent by industry, and SAINT II really caused the field to stop. Industry stopped investing in stroke; academic investment in stroke dried up. NIH funding became more difficult to get after SAINT II, and that really was sort of the really historical low moment in the development of treatment for stroke. Dr. Negar Asdaghi:         I was a resident when SAINT II came out, and I remember that somber feeling. Dr. Patrick Lyden:            It was a sad day. Dr. Negar Asdaghi:         Yeah. So, in the paper, you outline a number of potential causes as to why this translational failure may have occurred. But you highlighted the absence of preclinical scientific rigor as the most responsible source. And you already alluded to this a little bit. Can you please tell us a bit more? Dr. Patrick Lyden:            Absolutely. And first, of course, we have to say that the ideal clinical trial design is not available. We really don't know the absolute best way to test the drugs in human clinical trials. But leave that for another day. Dr. Patrick Lyden:            On the preclinical side, what can we say we're doing wrong? We're not sure, but one thing that has been highlighted over and over is that we don't approach preclinical characterization with as much rigor as we should. What do I mean by that? Animal models recapitulate for us some of the biology of a stroke, but not all. For example, many, many times we test a drug in a young model, an animal that's quite young, corresponding to a late teenager in human terms. Well, that's ridiculous. Stroke occurs in elderly people, and so on. So, the NIH called in a landmark conference for additional rigor, enhanced rigor. And I should mention the STAIR criteria were a first attempt at this. STAIR put out guidelines that said animals should be elderly, the animals should be randomized, et cetera, et cetera. And so that didn't happen. Although the STAIR criteria were out there, very few laboratories really committed to full rigor. And so the NIH funded the Stroke Preclinical Assessment Network, SPAN, to implement every aspect that we could think of that would add the best possible scientific design, the utmost rigor. So, we implemented true blinded assessment, true randomization, complete case ascertainment where we follow every single subject in the study and account for dropouts and subjects that don't complete the treatment, and, most importantly, a proper statistical design with adequate power and very large numbers. And the hypothesis that we're testing is that additional rigor in SPAN will lead to a better positive predictive value when we think about drugs that should go forward for testing in human stroke trials. Dr. Negar Asdaghi:         So, I think you already answered my next question, which was basically, why do you think SPAN is going to achieve what all others have failed to achieve? But I wanted to simplify and repeat what you mentioned. So, in simple terms, what SPAN is trying to do is to bring all preclinical research to a level of scientific rigor that was not necessarily present and make it a multicenter effort. And can you a little bit tell us about the different stages, again, of SPAN? Dr. Patrick Lyden:            Well, I'm not arguing that all preclinical research needs to be done following a SPAN type of model. Where SPAN fits in is at the end of a development project. So, if you want to characterize the cellular and molecular mechanisms, you don't need to do all of this rigor that we're doing. Just study the drug in the lab and do the mechanistic studies that need to be done. If you want to do dose finding, it doesn't need to be done this way. But at the end of that, OK, first we establish the mechanism, that's the first stage. Then we establish the toxicity. Then we establish target engagement. At the end, we are looking for some evidence that the drug will have a beneficial effect on outcomes. And in previous animal models, the only outcome, generally, the most common outcome that was studied, was size of the stroke. But in humans, the FDA does not recognize stroke size as a valid outcome. Dr. Patrick Lyden:            We look at function, most often measured with the Rankin score and the NIH Stroke Scale. So, we had to create a functional outcome, and then we had to study it at multiple laboratories to make sure we could replicate the effect across multiple sites. And we chose what's called a multi-arm, multi-stage (MAMS) statistical design. All the drugs start out in the experiment at the end of the first interim analysis, which is 25% of the sample size. We cull any compounds or treatments that appear futile are removed. Any that appear effective move on. At the end of the second stage, there's more culling. There's a total of four stages, and we're about to enter stage four, by the way. That's starting next week. And in stage four, there will be, at most, two, maybe only one treatment that has appeared non-futile and possibly effective for final characterization. Dr. Negar Asdaghi:         So, really interesting. I just want to highlight two important comments that you mentioned for our listeners again. So this is multi-layer, as you mentioned, multi-arm, multi-stages. It's sort of filter by filter, just ensuring that what we're seeing, the efficacy we're seeing in preclinical studies, will potentially be replicated in clinical studies. And what you mentioned that's very important is outcomes that classically is measured in animal models are infarct volume that are obviously very important but not necessarily may translate to exactly what we look at in clinical studies, which is functional outcomes, modified Rankin score and NIH Stroke Scale. So, with that, I want to then come back to the treatments that are actually being studied as part of SPAN. You have six very different agents as part of SPAN, from tocilizumab to uric acid. Why do you think these therapies will work? Dr. Patrick Lyden:            Well, my job as the PI of the coordinating center is to remain completely agnostic to the treatments. So, everybody's equal, and they all come in on an equal playing field. We actually have a mechanical treatment called remote ischemic conditioning, as well, and then five drugs. And these were selected through a peer review process at NIH. And then we were informed at the coordinating center what drugs we would be studying. Five drugs and one treatment. And then, of course, the challenge to us was to somehow create a blinded, randomized situation. Now, this turned out to be a fascinating, it's more mechanical, but how do you blind when some of the drugs are given orally, some are given intraperitoneally, some are given intravenously, some are given once, some are given multiple times? So, we had to work with the manufacturers and inventors of these drugs and figure out a way to package them, and in the paper, actually, there's a photograph in the appendix that shows we had to find these bottles that were amber-colored and how to load them and lyophilize the drug. Dr. Patrick Lyden:            And it's actually pretty fascinating how we were able to get all of these different, wildly different therapies, as you say, into a paradigm where they could be tested one against another in a truly blinded, truly randomized way. Dr. Negar Asdaghi:         Do you think you can go on record and say which one is your favorite? Dr. Patrick Lyden:            My favorite drug's not even in SPAN. I am truly agnostic because where my heart is, is with a drug that I've been studying in my laboratory completely separately and not part of SPAN. Dr. Negar Asdaghi:         All right, so we don't have a favorite. So, in a recent review article in Stroke, you commented on treatments used by ancient Persians, Greeks, and Romans to remedy the brain affected by stroke and how the future generation of physicians will look back at our current practices of stroke with the same, how you said, awe and bemusement we hold for Galen, Aristotle, and Avicenna. How do you think stroke will be treated in the year 2222? Dr. Patrick Lyden:            Well, first of all, and to be serious for just one moment, 200 years from now, I worry more about the climate than about medicine. And I really believe our biggest efforts need to be spent on saving the planet. But assuming we make it that long, obviously diagnostic methods will be completely different. Using ionizing radiation to scan the body will be laughed at by physicians in the future. There'll be detection technologies that aren't even on our radar yet today. And then treatments will be cellular focused and regionally focused. We give a drug through a vein and it circulates throughout the entire body, and I'm sure physicians in the future will find a way to somehow get treatment into the part of the body that's injured, not the whole body. And then, who knows? All we can say is they will laugh at us in the same way that we laugh at Theodoric the Barber of York. Dr. Negar Asdaghi:         Let's move on from the future to the past. You're arguably one of the founding fathers of reperfusion therapies. You were instrumental in getting intravenous lytic therapy approved in 1996. It literally took the field 20 years for the next treatment to be approved, that's endovascular treatment. If you could go back in time and give your young self an advice on the subject of research, of course, design and execution, what advice would you give yourself? Dr. Patrick Lyden:            Don't listen to old guys. We got a lot of advice from gray-bearded folks back when we were putting together the tPA trial, and fortunately we ignored some very bad advice and did what we imagined was the right thing to do as young, headstrong up-and-comers do. The other thing is, we really believed that by publishing our science very objectively, without editorial comment, we would be listened to. And that was dead wrong. So, the data was printed in the New England Journal in a very neutral tone, and we felt people would read that data and they would start using tPA the day after the publication. And, as you say, it took 20 years for tPA to really gain widespread acceptance, thrombolytic therapy. Today, people view it as standard, but it wasn't that way at the beginning. And I would say to myself and my colleagues at that time, "Don't be afraid to promote a positive result." Yes, it has to be done with the utmost rigor, but once you have a positive result, there will be plenty of people around pretending they know more than you and telling the world why you are wrong. And it's very important to stand up for your science and stand up for your results and say, no, no, no, no, that interpretation is wrong. The data says what we said it says, and this is an effective treatment and should be used, as an example. Dr. Negar Asdaghi:         What a great advice. Just be bold and say it loud and stand up for your science. Pat, it's been a pleasure interviewing you and having you on the podcast. We really look forward to watching your research. Bring, let me say it again, 2222 closer to now. Dr. Patrick Lyden:            Thank you. Glad to be here. Dr. Negar Asdaghi:         Thank you. Dr. Negar Asdaghi:         And this concludes our podcast for the May 2022 issue of Stroke. Please be sure to check out this month's table of contents for the full list of publications, including two articles on quality improvement in stroke and neurohospitalist—inpatient teleneurology, which comes as part of our Advances in Stroke series prepared by our section editors. And as we close our podcast today, let's take a moment and ask ourselves the same question that I asked Dr. Lyden earlier. What is the next frontier in stroke treatment? Past reperfusion therapies, we have to find ways to preserve the neurons and not just the neurons, all components of the brain. So, is the future of stroke therapy cerebroprotection? Ever since the dawn of history, humanity has lived alongside of death with the conscious apprehension that as we age, we lose the very gift of life. But unlike our ancestors, the search for immortality isn't the quest to find a fountain of youth anymore. We learned that death is inevitable, but with medicine, we can reduce illness and suffering to prolong a life worth living, one with a healthy brain. And today we're closer than ever to this modern immortality with cerebroprotection in stroke, as we stay alert with Stroke Alert. Dr. Negar Asdaghi:         This program is copyright of the American Heart Association, 2022. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association. For more, visit AHAjournals.org.  

Nicola Barber's expressive narration captures the inner life and scientific mindset of Rosalind Franklin, the great English biophysicist. Host Jo Reed and AudioFile contributor Alan Minskoff discuss how Barber is a wonderfully expressive reader of Marie Benedict's historical novel. The plot follows the real-life Franklin on her epoch-making research into the structures of DNA, RNA, and viruses. Barber's first-person narration provides an insider's feeling of the challenges experienced by a female scientist in the world of 1950s genetic research. Read the full review of the audiobook on AudioFile's website. Published by Audible, Inc. Find more audiobook recommendations at audiofilemagazine.com Support for AudioFile's Behind the Mic comes from PENGUIN RANDOM HOUSE AUDIO, dedicated to producing top-quality fiction and nonfiction audiobooks written and read by the best in the business. Visit penguinrandomhouseaudio.com/audiofile now to start listening. Learn more about your ad choices. Visit megaphone.fm/adchoices

John Barber is the Managing Partner of Cohesive Capital, a $1 billion private equity firm founded in 2010 to focus exclusively on private and growth equity co-investments. Cohesive executes its strategy without investing in funds and without paying a carry to sponsors. Our conversation covers John's early career in investment banking, the evolution of the industry, and the launch of Cohesive Capital. We dive into Cohesive's investment philosophy, deal structure, sourcing, and team. We then discuss his advice for other co-investors, and opportunities and risks in today's market. Learn More‍ Follow Ted on Twitter at @tseides or LinkedIn‍ Subscribe to the mailing list‍ Access Transcript with Premium Membership‍

Check out the full interview only on UFC FIGHT PASS.On this episode of Fitz Nation, Brendan Fitzgerald chats with UFC flyweight contender Maycee Barber.  Barber has packed a lot of life experience into her first 23 years.  She was just 20 years old when appearing on Dana White's Contender Series in 2018, getting a big win and earning a UFC contract.She has been thought of as a bright star and eventual championship challenger, but things didn't go according to plan in her goal to be the youngest ever UFC champion.  As always, the ups and downs of life come with valuable lessons, which she discusses on this episode.

In this episode, Nate Akin interviews Bart Barber about his nomination for SBC President. 

Tonight Jeff sits down with author, stand up comedian and multiple Emmy Award winning TV producer and writer Janette Barber. Join their totally uncensored conversation on life, comedy, the industry and working behind the scenes on one of daytime televisions biggest success stories, "The Rosie O'Donnell Show".

Wade Barber has put out two crazy albums with JFK & Statik Selektah as well as his recent solo album Barber all within the last 3 years. We talked alot about these releases on this episode. He's from Lynn, Mass so of course we talked about that, what he's working on this year, & much more. Follow Him at Wade Barber on all platforms. --- Support this podcast: https://anchor.fm/craigmosher/support

Sure the Cubs and Sox both had impressive victories last night, but Hood needs a new barber! How do you leave that kind of relationship? Your calls on Barbers, and barbershop relationships.

Host: Adam SommerGuest: Luke BarberAdam is joined for a chat by Luke Barber, a democrat and disability advocate running for the Missouri House in the 89th district. Luke explains why his diagnosis on the autism spectrum is an asset to his ability to represent the people of the 89th district in Missouri. https://heartlandpod.com/Twitter: @TheHeartlandPODChange The Conversation

Independent, investigative news, reporting, interviews and commentary

In this episode I go through Bart Barber FAQ on abortion. I have tried to get him to join me in a discussion since he publicly came out against equal justice last year after the SBC convention.

Imagine being a barber and making THIS mistake? It happened to Kyle and its on today's awkward moment!

Chaz 'ceehaz' Hazlitt is a celebrity barber, former hip-hop music manager, and co-owner of the infamous Stache Barber Shop in Union, New Jersey. Chaz and his daughter, Natalia co-authored, "Charlie's first Haircut" together - a children's book detailing the ins and out of getting your first haircut as a kid through the lens of Natalia's brother, and Chaz's son, Charlie. The two had no idea they'd reach the best-seller status on Amazon when they began the project on Google Docs as a way to have fun during the shutdown. We have to thank AK40DEVIN for introducing me to Chaz as well as his cousin, Ariel, the first barber I've ever had on the show. Purchase, "https://www.amazon.com/Charlies-First-Haircut-Chaz-Hazlitt/dp/B09TMYPN7D (Charlie's First Haircut.)" Follow https://www.instagram.com/ceehazthebarber/ (Chaz) Follow their https://www.instagram.com/charliesfirsthaircut/ (IG Page) Book a Cut at https://www.stachebarbers.com/ (Stache Barbers) Thank you for helping us become a top 10% podcast in the world! Previous Guests Include https://open.spotify.com/episode/4GLGc7gqDDDZdRqj4qlmwT?si=3306a470764646d5 (Rob Dyrdek), https://open.spotify.com/episode/2h9bHhMmQmL8WSSYDcj2mf?si=2a61889cb6244fe4 (Samad Savage), https://open.spotify.com/episode/2hudFx2Bh0no9aOpNVAfhL?si=b7f7c14b327f434b (Travis Chappell), https://open.spotify.com/episode/7r7aODbOtia2BjhG5GRcHh?si=ae47b9a90c21405d (Austin Belcak), https://open.spotify.com/episode/2ceJNa3MAyZlk8Lw3rsW1Q?si=e901236209e948f5 (Young Benny), https://open.spotify.com/episode/0qZVBnOGSUcAmt4EFphNcR?si=38763a2013084f6a (Adam Miller), https://open.spotify.com/episode/6lPiZinAXh3yDdSnLShDiA?si=74dc6a03560b4de9 (The Real Johnny Bravo), and more. Please Join Our Email List for Special Offers, Q+A's, Live Podcasts, and More - To Join, https://www.sullybop.com/ (Scroll to the Bottom of This Page) Links Below: _ Watch the Video Version on https://www.youtube.com/channel/UC5yW2ZNS4Iq7ff_EeKe3HkQ (YouTube) @sullybop on Instagram Search 'BOPCAST' on any platform! (Google Podcasts, Apple Podcasts, Spotify, YouTube) Visit https://www.sullybop.com/ (SullyBop.com) for more information. Big shouts to the folks who make this possible: Video - https://www.instagram.com/ferrarib98/ (@ferrarib98) Logo - https://www.instagram.com/ryannkelly20/ (@ryannkelly20) Producer - https://www.instagram.com/minishep13/ (@minishep13) Theme Song - https://www.instagram.com/jello.wav/ (@jello.wav)

Ready to get help?: https://calendly.com/the-new-era-of-barbering/1-on-1-zoom-call-web Check out what some of our customers have to say about the EM program: https://www.theneweraofbarbering.com/reviews Full breakdown of this video: https://youtu.be/HDStQF1BDPI Interested in what we do inside Elevated Mentorship? https://www.theneweraofbarbering.com

Perhaps few CFO career paths better reveal the advantages founder-led firm may offer than that of Prophix CFO Ryan Van Hatten. Back in 2016—when the firm's previous CFO exited the company—Prophix's founder and CEO, the late Paul Barber, asked Van Hatten, an 11-year company veteran, to step into the CFO office until a CFO hire could be made. Recalls Van Hatten: “I knew all of the people on the finance team, and they knew me, and we respected each other, so it was like, ‘Calm the troops, assess where we're at, and while this may take a few months, you can then go home to operations.'”     However, Van Hatten never did return to operations, and his ascension into the CFO role was finally set after Barber sold the software company to Canadian private equity firm HG Capital in early 2021.   Comments Van Hatten: “I was suddenly thrust into a different world. It was very different from having Paul and a bunch of friendly managers asking the questions.” Still, few CFOs likely would have been better prepared to answer sticky operational questions than Van Hatten, who had spent the balance of his 16-plus years at the software company zigzagging across the organization as Barber and COO Alok Ajmera (now CEO) summoned him to take on new and different roles.      Reports Van Hatten: “I had been around the company a long time. I knew the people, and if I had fallen flat on my face, they would have been there to help me and pick me up.” Asked what advantages a founder-led firm might offer to aspiring CFOs and what exactly sets apart the company that Paul Barber founded, Van Hatten says that this comes down to learning and relationships: “It's having the openness to learn from each other.” –Jack Sweeney

We read Aja Barber's debut book, Consumed, this month, + Morgan (@mostlyecomorgan) and I could wait to discuss it! Consumed: The Need for Collective Change: Colonialism, Climate Change, and Consumerism pushed us to reassess our frameworks on sustainability and fashion. We discuss major themes such as the international 'secondhand' market (read: >80% of donated clothes in the Global South are sent overseas), major financial disparities of multinational brands, + the pressure on consumers to both buy more and buy better. More for you: 135: The Real Problems with Fast Fashion: How Racism, Classism, + Saviorism Perpetuate an Exploitive System | Aja Barber Thanks to our sponsors today! OSEAmalibu.com with code "ECOCHIC" DailyHarvest.com/ECOCHIC Find me on: Instagram @ecochicpodcast + @lauraediez, on Facebook, Twitter, and now TikTok.

Got Faded Japan ep 641 We are delighted to bring you our Friday 13th special with Johnny and special guest, Scott from one of our favorite Tokyo bands, CREEP DOWN! FADE ON!   Get tracks, tour dates, merch, videos, and other CREEP DOWN info at: https://youtu.be/JlbikMbf9Gs https://www.facebook.com/creepdown14 IG: @creepdown13 https://creepdown.bandcamp.com/ https://mobile.twitter.com/creepdown14 https://open.spotify.com/album/4dlXxjHy8ftDRYIJvxqRIh -------------------------------------------------------------------------------- Supporting GOT FADED JAPAN ON PATREON directly supports keeping this show going and fueled with booze, seriously could you imagine the show sober?? Neither can we! SUPPORT GFJ at: https://www.patreon.com/gotfadedjapan   -------------------------------------------------------------------------------- CHECK OUT OUR SPONSORS AND SUPPORT THE SHOW!!!!   1. THE SPILT INK: Experience art, buy art and get some original art commissioned at: SITE: https://www.thespiltink.com NFT: https://rarible.com/thespiltink ETSY: https://www.etsy.com/shop/TheSpiltInk?ref=hdr_shop_menu --------------------------------------------------------------------------------  2. Soul Food House https://soulfoodhouse.comAddress:2-chōme−8−10 | Azabujūban | Tokyo | 106-0045 Phone:03-5765-2148 Email:info@soulfoodhouse.com Location Features:You can reach Soul Food House from either the Oedo Line (get off at Azabujuban Station and it's a 7-minute walk) or the Namboku Line (get off at Azabujuban Station and it's a 6-minute walk). --------------------------------------------------------------------------------  3. Ghost Town Pomade FADE IN STYLE with Ghost Town Pomade.Get yours today by contacting: ghosttownpomade@gmail.com  -------------------------------------------------------------------------------- 4. MITSUYA LIQUOR in ASAGAYA: 1　Chome- 13 -17 Asagayaminami, Suginami Tokyo 166-0004　 Tel & Fax: 0303314-6151Email: saketoyou0328@gmail.com --------------------------------------------------------------------------------   5. Harry's Sandwich Company 1 min walk from Takeshita Street in HarajukuCall 050-5329-7203 Address: 〒150-0001 Tokyo, Shibuya City, Jingumae, 1 Chome−16−7 MSビル 3F https://www.facebook.com/harryssandwichco/ -------------------------------------------------------------------------------- 6. Share Residence MUSOCO “It's a share house that has all that you need and a lot more!” - Located 30 minutes form Shibuya and Yokohama - Affordable rent - Gym - BAR! - Massive kitchen - Cozy lounge space - Office work units - A spacious deck for chilling - DJ booth and club space - Barber space - AND MORE! Get more info and move in at: https://sharedesign.co.jp/en/property.php?id=42&property=musaco&fbclid=IwAR3oYvB-a3_nzKcBG0gSdPQzxvFaWVWsi1d1xKLtYBnq8IS2uLqe6z9L6kY -------------------------------------------------------------------------------- GET YOURSELF SOME GOT FADED JAPAN MERCH TODAY!!! We have T-Shirts, COFFEE Mugs, Stickers, even the GFJ official pants! BUY NOW AND SUPPORT THE SHOW: http://www.redbubble.com/people/thespiltink/works/16870492-got-faded-japan-podcast  -------------------------------------------------------------------------------- The Got Faded Japan Podcast gives listeners a glimpse of the most interesting side of Japan's news, culture, peoples, parties, and all around mischief and mayhem. Hosted by Johnny and Jeremy who adds opinions and otherwise drunken bullshit to the mix. We LOVE JAPAN AND SO DO YOU! Send us an email on Facebook or hell man, just tell a friend & post a link to keep this pod rolllin' Fader! Kanpai mofos!

The "business in the front, party in the back" look is apparently on its way back to the fashion spotlight. WBZ's James Rojas reports:

In our latest edition of our Author Interview Series, recent interview subject Andy McCue goes to the other side of the microphone to discuss "Red Barber: The Life and Legacy of a Broadcasting Legend" with it's co-authors Judith R. Hiltner and James R. Walker. They discuss the voice behind the legendary Brooklyn Dodgers, what he meant to broadcasting and the game overall.

Thank you for tuning in to episode 15 of the Cheap Flights and Cornbread Podcast. On this episode, we welcome on Capital Region photographer Braiton Barber onto the show!

Does Will really hate Edge? Can all these victims of the one word names trend survive the gimmick? What the hell is a mid-card star? Well, we guess you'll have to listen to find out! Jaded Wrasslin' Merch: prowrestlingtees.com/jadedwrasslin Follow the family on Twitter: @Jadedwrasslin @yearofpod @totspod @g0dfieri @Taylorhasler1 @JobenRogue @redbeardpirate1 @duke_baggs Jaded Wrasslin' Social Media! https://linktr.ee/Jadedwrasslin --- Send in a voice message: https://anchor.fm/jadedwrasslin/message Support this podcast: https://anchor.fm/jadedwrasslin/support

Dan Barber is on a mission to quite literally plant seeds for a better future. Around a decade ago, after learning that the nation's largest food companies rarely breed food for flavor—and instead select for self-serving characteristics, such as the ability to produce high yields or endure long-distance travel—Barber, a chef and the co-owner of the restaurants Blue Hill in Manhattan and Blue Hill at Stone Barns in Tarrytown, New York, turned his attention to seeds. From there, he collaborated with a vegetable breeder to make the honeynut squash, a sweeter, healthier version of the butternut variety, and has since used his cooking to raise awareness about the vital roles seeds can play in our food system. A co-founder of the seed company Row 7, he is not only concerned with the beneficial impacts seeds can have on taste buds, but also on communities and the planet.Rethinking what people eat has played a constant role in Barber's practice. His cooking style, honed at restaurants including Alice Waters's Chez Panisse, favors minimal ingredients as a way of celebrating their distinctive tastes. His upstate restaurant sits on a property shared with the Stone Barns Center for Food & Agriculture, a nonprofit operation that includes a regenerative farm and robust educational programming; there, his Blue Hill kitchen staff works with the Stone Barns teams to develop new ideas around food and farming. Barber regularly hosts educational programs, too, such as WastED, a 2015 pop-up that served delicious dishes made from ingredients most of us would consider trash.On this episode, Barber talks with Andrew about the distinctive role that restaurants can play in supporting social movements, food scraps as part of a chef's DNA, and why producing more food won't solve food insecurity.Special thanks to our Season 5 sponsor, L'ÉCOLE, School of Jewelry Arts.Show notes:Full transcriptResourcED [05:07]Stone Barns Center for Food & Agriculture [09:09]Blue Hill and Blue Hill at Stone Barns [15:11]The Third Plate [15:11]Row 7 [27:35]Michael Mazourek [27:35]Eliot Coleman [51:43]WastED [01:00:32]

James Barber is the Off Duty editor for Military.com. James writes on topics like entertainment and the military. Barber talks with host Jim Fausone about the military movies set to premiere in 2022; the good and the bad. James is candid and interesting to speak with as always.

Gilbert Paul Jordan, a former barber was linked to the deaths of upwards of 10 women. The boozing barber's weapon of choice was death by alcohol, he was the first Canadian known to use alcohol as a murder weapon.MERCH:https://www.redbubble.com/people/wickedandgrim/shop?asc=uPatreon: https://www.patreon.com/wickedandgrim?fan_landing=true Facebook:Facebook: https://www.facebook.com/wickedandgrim/ Instagram:Instagram: https://www.instagram.com/wickedandgrim/?hl=enTwitter: https://twitter.com/wickedandgrimWebsite: https://www.wickedandgrim.com/Links:The Vancouver Sun Special Report, "Death by Alcohol"https://murderpedia.org/male.J/j/jordan-gilbert-paul.htmhttps://www.cbc.ca/news/canada/predator-back-in-jail-1.236346https://www.theglobeandmail.com/news/national/release-of-boozing-barber-spurs-warning/article1139374/ Get bonus content on Patreon See acast.com/privacy for privacy and opt-out information.

This week we sit down with Singer Songwriter Del Barber. Del spends a lot of time fly fishing some epic water while on the road as an Alt Country, Folk Rock artist. His passion for the water is impressive and constant, he joins us to talk about his fly fishing journey, what it brings into his world, the inspiration it brings to his music and life journey. You can find Del's music at delbarber.com or wherever you download your music. Thanks Del for this candid chat about life, the road, the river and your songs.

On this week's episode of the Pulse Pod, Chris and Brent are joined by Dr. Frederick Barber, President of Response: AI, a full service and self-service market research firm which is a current partner of Cygnal's. Together, they take a close look into Ad Testing–its advantages over other research methods such as Focus Groups, and its differences from standard polling.

In this episode of Film Stories with Simon Brew, two films that both interested Oscar-winning directors - and ended up with different ones. Steven Spielberg was originally pursuing directing Interstellar. But it was in part for reasons not related to the film he stepped away - and Christopher Nolan took over. The big screen take on the musical Sweeney Todd: The Demon Barber Of Fleet Street meanwhile had Sam Mendes linked for a while. But it'd be Tim Burton who steered it to the screen - and the trailer proved to be quite infamous. Stories of both are told in this episode. Find Simon on Twitter at @simonbrew, and the podcast can be found at @filmstoriespod. Support this podcast: www.patreon.com/simonbrew.

Ready to get help? Book a call, Brian did, and was able to raise his haircut price to $75: https://calendly.com/the-new-era-of-barbering/1-on-1-zoom-call-web Check out what some of our customers have to say about the EM program: https://www.theneweraofbarbering.com/reviews Full breakdown of this video: https://youtu.be/UeEiIzHR2es Interested in what we do inside Elevated Mentorship? https://www.theneweraofbarbering.com

SUP TDAD Fam & Happy Mother's Day!WE ARE BACK!!! THE BISCUITS ARE BACK , THE POD IS BACK EVERYTHING , IS BACK!“We're mass communicating!” Listen to the latest episode of @tdadbaby with @BarberShreds. Episode 42 is fresh off the mic: Jon recaps the epicness that was the @missionballroom and why tDB loves the venue. Barber banters over some jams from The Disco Biscuits first shows @The Mission Ballroom in Denver, CO. "Essentially the perfect balance of just listening & commentary." -- Dave DreadWe give you "E042: We Got A Brand New Mission " We are looking back at the show played on Saturday night 4/9/2022 in Denver, and in particular S2. Happy Mother's Day!!! Tell your friends! We Mass Communicatin' Let's roll this out!E042 - Mission Ballroom 4/9/22 S21.) I-MAN > M12.) EVOLVE > CATEPILLAR3.) SAVE THE ROBOTSCrunk Mike & a few other Bisco Twitter/discord heads are dubbing this the Best Biscuits this year, even w/ that Richmond Bonus Show & Barber B-Day show @ the Cap. It's A certified Rager of a concert. The band is firing on all cylinders right now and headed into a big Summer Tour w/ Umphrey's McGee & City Bisco. Bring yo' ass to the parties.Bless you all! Glory to Bisco in the highest. Cover photos by Sean GillisCover Art by Ricky's PlaceHosted by Jon "The GOAT" BarberMixed by Keith BillikWho the F is CM?!Special thx to the TDAD SQUAD - IYKYKPeace & Love, Stay fuckin' fresh!The Disco Biscuits are incredible & these men make up the band:Aron MagnerAllen AucoinMarc BrownsteinIce Cold Jonny BarberSupport this show http://supporter.acast.com/touchdownsallday. See acast.com/privacy for privacy and opt-out information.

Got Faded Japan ep 640 Johnny, Tom and Missy interview “JORDAN”, an American gigolo living in Japan. “Jordan” bitch slaps us with his pimp game and schools us on the “ins and outs” of living the gigolo life in Japan! FADE ON!   -------------------------------------------------------------------------------- Supporting GOT FADED JAPAN ON PATREON directly supports keeping this show going and fueled with booze, seriously could you imagine the show sober?? Neither can we! SUPPORT GFJ at: https://www.patreon.com/gotfadedjapan   -------------------------------------------------------------------------------- CHECK OUT OUR SPONSORS AND SUPPORT THE SHOW!!!!   1. THE SPILT INK: Experience art, buy art and get some original art commissioned at: SITE: https://www.thespiltink.com NFT: https://rarible.com/thespiltink ETSY: https://www.etsy.com/shop/TheSpiltInk?ref=hdr_shop_menu --------------------------------------------------------------------------------  2. Soul Food House https://soulfoodhouse.comAddress:2-chōme−8−10 | Azabujūban | Tokyo | 106-0045 Phone:03-5765-2148 Email:info@soulfoodhouse.com Location Features:You can reach Soul Food House from either the Oedo Line (get off at Azabujuban Station and it's a 7-minute walk) or the Namboku Line (get off at Azabujuban Station and it's a 6-minute walk). --------------------------------------------------------------------------------  3. Ghost Town Pomade FADE IN STYLE with Ghost Town Pomade.Get yours today by contacting: ghosttownpomade@gmail.com  -------------------------------------------------------------------------------- 4. MITSUYA LIQUOR in ASAGAYA: 1　Chome- 13 -17 Asagayaminami, Suginami Tokyo 166-0004　 Tel & Fax: 0303314-6151Email: saketoyou0328@gmail.com --------------------------------------------------------------------------------   5. Harry's Sandwich Company 1 min walk from Takeshita Street in HarajukuCall 050-5329-7203 Address: 〒150-0001 Tokyo, Shibuya City, Jingumae, 1 Chome−16−7 MSビル 3F https://www.facebook.com/harryssandwichco/ -------------------------------------------------------------------------------- 6. Share Residence MUSOCO “It's a share house that has all that you need and a lot more!” - Located 30 minutes form Shibuya and Yokohama - Affordable rent - Gym - BAR! - Massive kitchen - Cozy lounge space - Office work units - A spacious deck for chilling - DJ booth and club space - Barber space - AND MORE! Get more info and move in at: https://sharedesign.co.jp/en/property.php?id=42&property=musaco&fbclid=IwAR3oYvB-a3_nzKcBG0gSdPQzxvFaWVWsi1d1xKLtYBnq8IS2uLqe6z9L6kY -------------------------------------------------------------------------------- GET YOURSELF SOME GOT FADED JAPAN MERCH TODAY!!! We have T-Shirts, COFFEE Mugs, Stickers, even the GFJ official pants! BUY NOW AND SUPPORT THE SHOW: http://www.redbubble.com/people/thespiltink/works/16870492-got-faded-japan-podcast  -------------------------------------------------------------------------------- The Got Faded Japan Podcast gives listeners a glimpse of the most interesting side of Japan's news, culture, peoples, parties, and all around mischief and mayhem. Hosted by Johnny and Jeremy who adds opinions and otherwise drunken bullshit to the mix. We LOVE JAPAN AND SO DO YOU! Send us an email on Facebook or hell man, just tell a friend & post a link to keep this pod rolllin' Fader! Kanpai mofos!  

Alex and James recap their weekends in Barber. The guys then discuss the upcoming Formula One race in Miami this weekend, then we do another special two-parter of Ask Alex. Send in your Ask Alex questions to AskOffTrack@gmail.com! Then, we announce our Live Show, the Greatest Spectacle in Podcasting, with Joey Mulinaro and Conor Daly's podcast, Speed Street.+++Subscribe to our YouTube Channel.Follow us on Twitter at @askofftrack. Or individually at @Hinchtown, @AlexanderRossi, and @TheTimDurham.The music you heard in this episode comes from:Ryan Dann of Holland Patent Public Library. You can find him online at hollandpatentpubliclibrary.com

Graham Rahal and Romain Grosjean's collision and subsequent post-race spat is the main topic of conversation on this edition of The Race IndyCar Podcast, which looks back on an epic weekend at Barber Motorsports Park. JR Hildebrand breaks down Grosjean and Rahal's wheel-banging incident from a drivers' perspective, while co-host Jack Benyon gives his view on why Rahal went too far in his post-race comments - even if more rivalry between drivers in IndyCar is welcome. The boys also discuss Arrow McLaren SP's start to the season in the wake of a tide-turning victory for Pato O'Ward, who's triumph comes off the back of headlines about going to 'war' with his team in trying to agree a new contract. The podcast also looks at Penske's decision not to test pre-race, Rinus VeeKay's pole and where he compares to Josef Newgarden who previously won races for Ed Carpenter, plus there's an explanation of the two key strategies that defined the race. Follow The Race on Instagram, Twitter and Facebook Check out our latest videos on YouTube For IndyCar news, analysis and must-read features visit the-race.com

In 1942, the young girls and women of Pascagoula, Mississippi were targeted by a burglar with very specific taste. Our Tuesday episodes are usually shorter than our Friday episodes, focusing on topics we didn't think we could do a full episode on, and often sent in by you guys! There's bonus content, ad-free episodes, and other perks on our Patreon! https://www.patreon.com/witchesmagicmurdermystery Podcast store: https://witches-magic-murder-mystery-podcast-store.myshopify.com Source: https://www.gulflive.com/mississippi-press-news/2014/03/pascagoulas_phantom_barber_rep.html All Witches, Magic, Murder, & Mystery episodes are a mix of Kara and Megan's personal thoughts and opinions in response to the information that is publicly available at the time of recording, as well as, in some cases, personal accounts provided by listeners. In regard to these self-reported personal accounts, there can be no assurance that the information provided is 100% accurate. If you love the Trash Witch art (see our Patreon or the Podcast store), Tiffini Scherbing of Scherbing Arts created her. Find her art page on Facebook! Check out @witchesmagicmurdermystery on Instagram, or find our Facebook group by searching “Witches, Magic, Murder, & Mystery Podcast Discussion Group.” Email every single weird story you've got to witchesmagicmurdermystery@gmail.com. Get to know us better: Kara: @atoakandmain Megan: @meganmakesjokes on TikTok Theme music: Chloe's Lullaby by Robert Austin. Available on Spotify, Google Play, YouTube, Bandcamp, and Patreon!

Monday night on Trackside, Kevin Lee and Curt Cavin return for nightly shows in the Month of May! They discuss the exciting IndyCar race at Barber Motorsports Park, won by Pato O'Ward, with Alex Palou and Rinus VeeKay rounding out the podium. Kevin and Curt break down how the race was won, the different pit stop strategies, and how the championship standings are shaking out four races in. They talk about O'Ward's turn around after his “war with his team,” and his contract situation.  Our News of the Day brought to you by the Indianapolis Speedrome and Circle City Raceway is that Alex Palou is back in the lead of the championship standings heading to the GMR Grand Prix. Later, Curt and Kevin discuss the conflict between Graham Rahal and Romain Grosjean, and give the latest on the 33rd entry for the Indy 500.  See omnystudio.com/listener for privacy information.

CLICK TO SUBSCRIBE TO THE SB NATION NFL SHOW: Subscribe on Apple Podcasts Subscribe on Spotify The SB Nation NFL Show brings together the greatest fan-alysts from across SB Nation's NFL team communities in one place for the first time ever. Expect deep analysis, irreverent jokes, and plenty of bickering between rivals. It's a show for NFL fans, by NFL fans.   Monday - Monday Football Monday (RJ Ochoa, Pete Sweeney) Tuesday - Off Day Debrief (Brandon Lee Gowton, Rob "Stats" Guerrera) Wednesday - NFL University (Kyle Posey, Stephen Serda, Justis Mosqueda) Thursday - The Look Ahead (RJ Ochoa, Rob "Stats" Guerrera) Friday - NFL Reacts (Stephen Serda, Justis Mosqueda, Kate Magdziuk) Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode 31: Big Jay the Barber is responsible for the hairstyles of Batista, Sheamus, Tyson Kidd and many more from the world of professional sports. The New Day's Big E frequents his shop and invited him to be this week's guest on the podcast. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today, I feel honored to share the first of two episodes with one of my favorite women in the health and wellness space! Dr. Tabatha Barber is a triple board-certified OB-Gyn specializing in perimenopause, menopause, and functional medicine. She is often affectionately referred to as the Gutsy Gynecologist, and she has a wonderful podcast called The Gutsy Gynecologist Show. Dr. Barber is speaking out on behalf of middle-aged women! She does not focus on any specific age group because she prefers to think about women on a continuum.  In this episode, she talks with me about perimenopause, lifestyle management, and navigating the transition to middle age. We discuss the impact of oral contraceptives, their effect on the gut microbiome, and informed consent. We talk about vitamin and mineral depletion and therapies typically used in middle age- including IUDs, ablations, and hysterectomies. We dive into how to navigate cycle mapping and successfully integrate intermittent fasting during perimenopause. We also briefly touch on how to manage vasomotor symptoms.  I hope you will gain a lot from this invaluable podcast! We will be sharing the second part of this show later this summer. Stay tuned for more! IN THIS EPISODE YOU WILL LEARN: Dr. Barber explains what inspired her to help and support women throughout their lifetime. What changes happen in women's bodies as they move past the peak fertility years?   How do we prepare for the time when our bodies are no longer fertile? It is vital to make the connection between gut health and gynecological health. The issue with birth control pills. How can women who have IUDs, or those who have had an ablation or a hysterectomy and still have their ovaries, understand where they are in their cycle? Why is so little research done on women, and why are women not getting the care they deserve from their medical practitioners? Problems that exist within the current medical system. Women need to ask their health care providers “why?”. How to manage vasomotor symptoms. Connect with Cynthia Thurlow Follow on Twitter, Instagram & LinkedIn Check out Cynthia's website  Connect with Dr. Tabatha Barber On her website The Gutsy Gynecologist Show On Instagram and TikTok

Install Raid for Free Mobile and PC: https://clik.cc/QFagp and get a special starter pack Available only for the next 30 daysFormer UFC middleweight champion Michael Bisping and #5 Ranked UFC light heavyweight Anthony Smith welcome on Maycee Barber to talk about her win at the weekend, life since joining Team Alpha Male, backing up her confident persona, and more then Mackenzie Dern joins to talk her fight with Tecia Torres, why it's hard to get fighters to follow her to the ground and so much more, plus recapping Tyson Fury defending his title at Wembley, Andrade catching the first standing arm triangle in UFC history and so much more!This episode was recorded on 4.18.22Support Our Sponsorshttps://www.betterhelp.com/believe/ - Click the link for 10% off your first monthhttps://www.ipvanish.com/believe - Follow the link to protect your internet privacy for as low as $3.49 per month!Believe You Me is available for early pre release on GaS Digital Network every Monday. Sign-up with code BYM to get access to the archives, bonus content and more! https://bit.ly/2YXEoZH"Free Cain" Shirts Herehttps://derekbrunson.com/collections/mensFollow the show on social media:Twitter: https://twitter.com/BYMPodSubscribe on YouTube: https://bit.ly/3drq6psFollow the hosts on social:Michael Bisping Twitter https://twitter.com/bispingMichael Bisping Instagram https://www.instagram.com/mikebisping/Michael Bisping YouTube https://www.youtube.com/channel/UCDrG2_1TcVkXKXXsD6KjwigWebsite https://gasdigitalnetwork.com/gdn-show-channels/believe-you-me/Anthony Smith Twitter: https://twitter.com/lionheartasmithAnthony Smith Instagram: https://www.instagram.com/lionheartasmith/Mike's debut book "Quitters Never Win" is available wherever books are sold, click here to get a copy! https://bit.ly/2V9ZqDkFollow the team on social:Brian MacKay Instagram: https://www.instagram.com/bmackayisrightBrian MacKay Twitter: https://twitter.com/bmackayisrightMike Harrington Twitter: https://twitter.com/TheMHarringtonMike Harrington Instagram https://www.instagram.com/themharringtonMike Harrington Twitch https://www.twitch.tv/themharringtonBelieve You Me is a twice weekly podcast covering MMA news in a comedy podcast format hosted by former UFC Middleweight Champion Michael Bisping.Michael Bisping is a Former UFC Middleweight Champion. He transitioned to commentary in his post fight career and regularly calls the biggest fights. In addition to analyst work Michael has been cast in shows on Netflix, CBS and Showtime and has appeared in movies such as XXX: Return of Xander Cage, Den Of Thieves and Triple Threat. His next project slated for release is Warrior on Netflix in October, his self titled documentary "Bisping" is out now and just made #1 on the US and UK charts.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.